The Board has determined that the Veteran's onychomycosis, a fungal infection of his toenails, warrants a 10 percent rating under DC 7804 due to painful and hypertrophic nails affecting less than 5% of his entire body. The condition does not involve exposed areas or require systemic therapy.
The deciding factor: The Veteran's onychomycosis has been manifested by recurrent fungal infections resulting in thickened, discolored, hypertrophic and painful great toenails treated with antiobiotics, antifungal medications and debridement; the onychomycosis does not involve an exposed area, involves less than 5 percent of the Veteran's entire body and has not required corticosteroid or other immunosuppressive drug for any time during the appeal period.
- Claimed conditions
- onychomycosis
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 10%
- Decision date
- December 27, 2016
- Citation
- 1648063
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 1648063.
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Veteran's claim for an initial compensable disability rating for onychomycosis was denied as the condition did not require treatment and covered less than 5% of his body. The Board also remanded issues regarding service connection for left ear hearing loss and entitlement to a compensable disability rating for right ear hearing loss.
- Remanded (sent back)
The Veteran's claims for increased ratings of his service-connected toenail disabilities and service connection for lumbosacral strain, joint pain, and an acquired psychiatric disorder are being remanded due to the need for further development.
- Dismissed
The Veteran withdrew his appeals for all the listed conditions in April 2024 and March 2025, thus dismissing the appeal.
- Remanded (sent back)
The Veteran's onychomycosis is rated under the old criteria and remanded for further development to determine if systemic therapy, such as fluconazole, is similar to corticosteroids or immunosuppressive drugs.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.